These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
188 related articles for article (PubMed ID: 3495310)
1. Endothelium-derived relaxing factor inhibits in vitro platelet aggregation. Furlong B; Henderson AH; Lewis MJ; Smith JA Br J Pharmacol; 1987 Apr; 90(4):687-92. PubMed ID: 3495310 [TBL] [Abstract][Full Text] [Related]
2. Comparative pharmacology of endothelium-derived relaxing factor, nitric oxide and prostacyclin in platelets. Radomski MW; Palmer RM; Moncada S Br J Pharmacol; 1987 Sep; 92(1):181-7. PubMed ID: 3311265 [TBL] [Abstract][Full Text] [Related]
3. YC-1 inhibited human platelet aggregation through NO-independent activation of soluble guanylate cyclase. Wu CC; Ko FN; Kuo SC; Lee FY; Teng CM Br J Pharmacol; 1995 Oct; 116(3):1973-8. PubMed ID: 8640334 [TBL] [Abstract][Full Text] [Related]
4. Thimerosal blocks stimulated but not basal release of endothelium-derived relaxing factor (EDRF) in dog isolated coronary artery. Crack P; Cocks T Br J Pharmacol; 1992 Oct; 107(2):566-72. PubMed ID: 1384915 [TBL] [Abstract][Full Text] [Related]
5. Activation of guanylate cyclase and inhibition of platelet aggregation by endothelium-derived relaxing factor released from cultured cells. Hawkins DJ; Meyrick BO; Murray JJ Biochim Biophys Acta; 1988 May; 969(3):289-96. PubMed ID: 2897209 [TBL] [Abstract][Full Text] [Related]
6. Human vascular smooth muscle cells inhibit platelet aggregation when incubated with glyceryl trinitrate: evidence for generation of nitric oxide. Benjamin N; Dutton JA; Ritter JM Br J Pharmacol; 1991 Apr; 102(4):847-50. PubMed ID: 1906768 [TBL] [Abstract][Full Text] [Related]
11. Endothelium-derived relaxing factor (EDRF): a defence mechanism against platelet aggregation and vasospasm in human coronary arteries. Förstermann U; Mügge A; Alheid U; Bode SM; Frölich JC Eur Heart J; 1989 Nov; 10 Suppl F():36-43. PubMed ID: 2620689 [TBL] [Abstract][Full Text] [Related]
12. Inhibition of platelet aggregation by carbon monoxide is mediated by activation of guanylate cyclase. Brüne B; Ullrich V Mol Pharmacol; 1987 Oct; 32(4):497-504. PubMed ID: 2890093 [TBL] [Abstract][Full Text] [Related]
13. Desensitization of platelet thromboxane A2/prostaglandin H2 receptors by the mimetic U46619. Liel N; Mais DE; Halushka PV J Pharmacol Exp Ther; 1988 Dec; 247(3):1133-8. PubMed ID: 2974487 [TBL] [Abstract][Full Text] [Related]
14. Interaction of human platelets and leukocytes in modulation of vascular tone. Kaul S; Waack BJ; Padgett RC; Brooks RM; Heistad DD Am J Physiol; 1994 May; 266(5 Pt 2):H1706-14. PubMed ID: 8203570 [TBL] [Abstract][Full Text] [Related]
15. Endothelium-derived relaxing factor from cultured human endothelial cells inhibits aggregation of human platelets. Alheid U; Frölich JC; Förstermann U Thromb Res; 1987 Sep; 47(5):561-71. PubMed ID: 3499684 [TBL] [Abstract][Full Text] [Related]
16. The potentiation of phorbol ester-induced aggregation of human platelets by the prostaglandin endoperoxide analogue, U46619. Edwards MC; Williamson EM; Evans FJ J Pharm Pharmacol; 1987 May; 39(5):370-7. PubMed ID: 2886585 [TBL] [Abstract][Full Text] [Related]
17. Antiaggregatory activity of 8-epi-prostaglandin F2 alpha and other F-series prostanoids and their binding to thromboxane A2/prostaglandin H2 receptors in human platelets. Yin K; Halushka PV; Yan YT; Wong PY J Pharmacol Exp Ther; 1994 Sep; 270(3):1192-6. PubMed ID: 7932171 [TBL] [Abstract][Full Text] [Related]
18. Inhibition by nitroprusside of platelet calcium mobilization: evidence for reduced sensitivity to nitric oxide in essential hypertension. Woods JD; Edwards JS; Ritter JM J Hypertens; 1993 Dec; 11(12):1369-73. PubMed ID: 8133019 [TBL] [Abstract][Full Text] [Related]
19. Synergistic inhibition of platelet aggregation by endothelium-derived relaxing factor and prostacyclin. Macdonald PS; Read MA; Dusting GJ Thromb Res; 1988 Mar; 49(5):437-49. PubMed ID: 3287674 [TBL] [Abstract][Full Text] [Related]
20. [Inhibition of platelet activation by endothelium-derived relaxing factor EDRF/NO and NO releasing dilator substances]. Bassenge E Z Kardiol; 1991; 80 Suppl 5():17-21. PubMed ID: 1776330 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]